Inflammatory Diseases Not Yet Recruiting Phase 2 Trials for Tocilizumab (DB06273)

Also known as: Inflammatory Disease

IndicationStatusPhase
DBCOND0041144 (Inflammatory Diseases)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03651518Personalized Therapies in Inflammatory Complex DiseaseTreatment